Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | Value of radiomics and AI in cancer treatment

Venkata Pradeep Babu • 12 May 2020
ESMO Breast 2020
Breast Cancer

Venkata Pradeep Babu, MBBS, MD, DNB, of the Rajiv Gandhi Cancer Institute, New Delhi, India, discusses the importance of radiomics and AI in cancer treatment. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Venkata Pradeep Babu

3:31
Correlation between CEA and TNM stage in CRC
Venkata Pradeep Babu • 10 Jul 2020
3:59
COVID-19 management in India
Venkata Pradeep Babu • 10 Jul 2020
4:40
Role of radiomics in intrahepatic CCA clinical prognosis
Venkata Pradeep Babu • 10 Jul 2020
4:26
Radiomics in the prediction of immunophenotypes in male breast cancer
Venkata Pradeep Babu • 6 May 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals